Skip to main content
RAPP
NASDAQ Life Sciences

Major Shareholder Third Rock Ventures Files Intent to Sell Additional Shares Amidst Ongoing Distribution

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$39.71
Mkt Cap
$1.899B
52W Low
$7.73
52W High
$42.269
52W Position info
414% above low
Off High info
6.1% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

RAPP has more than doubled off its 52-week low of $7.73.

Summary

Third Rock Ventures, a 10% owner, filed a Form 144 to sell an additional $742,880 in shares, continuing a pattern of significant institutional selling that has exceeded $70 million in the last three months.


Key Events · Ownership and Investor Activity · RAPP

  • Intent to Sell Additional Shares

    Third Rock Ventures V, L.P., a 10% shareholder, filed a Form 144 indicating intent to sell 18,572 common shares, valued at approximately $742,880.

  • Ongoing Institutional Distribution

    This filing also reports that Third Rock Ventures has sold 836,136 shares for gross proceeds of over $70.5 million in the past three months, signaling a continued pattern of significant selling by a major institutional investor.


Analysis · RAPP · Life Sciences

This Form 144 filing indicates Third Rock Ventures V, L.P., a 10% shareholder, intends to sell an additional $742,880 worth of common stock. This follows significant sales by the same entity totaling over $70 million in the past three months, representing a continued pattern of distribution by a major institutional investor.

How filings like this one have moved

In the 30 days to Nov 9, 2026, 36.6% of the 2965 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, RAPP was trading at $39.71 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $7.73 to $42.27. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

RAPP - Latest Insights

RAPP
Nov 04, 2026, 7:12 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $25.48
Real-time Price: $24.44 info
Change: -$1.04 (-4%) info
Market Cap: $1.173B info
RAPP
Oct 30, 2026, 7:32 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $24.56
Real-time Price: $24.44 info
Change: -$0.120 (-0.49%) info
Market Cap: $1.173B info
RAPP
Oct 30, 2026, 5:12 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $25.56
Real-time Price: $24.44 info
Change: -$1.12 (-4%) info
Market Cap: $1.173B info
RAPP
Oct 30, 2026, 7:04 AM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $22.55
Real-time Price: $24.44 info
Change: +$1.89 (+8%) info
Market Cap: $1.173B info
RAPP
Oct 28, 2026, 6:18 AM EDT
Filing Type: FWP
Importance Score:
8
Price at Filing: $21.80
Real-time Price: $24.44 info
Change: +$2.64 (+12%) info
Market Cap: $1.173B info